Global Arteriovenous Malformations Market
HealthcareServices

Global Arteriovenous Malformations Market 2025–2029: Unveiling Growth Developments with the Latest Updates

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Arteriovenous Malformations Market Be Worth By 2029?

The market size for arteriovenous malformations has experienced significant growth in the past few years. It is projected to increase from $2.88 billion in 2024 to $3.1 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The historical growth can be linked to a rise in arteriovenous malformations incidence, an increase in neurological or brain disorder prevalence, a heightened demand for improved treatment for rare diseases, enhanced government backing for research and development, and an expanding business sector.

Anticipated robust expansion is on the horizon for the arteriovenous malformations market, as it’s projected to reach a value of $4.1 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.2%. This surge over the forecast period is attributed to several factors including the increasing utilization of gene therapy, the escalating demand for cutting-edge medical technology, growing demand for high-quality healthcare services, increasing consumption of neurological medications, and growth arising from the aging population. Some key trends expected during this forecast period are progress in therapeutic options, breakthroughs in medical technology, advancements in microsurgical techniques, innovations in catheter technology, and progressions in minimally invasive surgeries.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21888&type=smp

What Market Forces Are Contributing To The Growth Of The Arteriovenous Malformations Market?

The arteriovenous malformations market is expected to experience robust growth due to the increasing preference for minimally invasive procedures. These are medical interventions executed via small incisions or catheter methods to minimize recovery period and potential complications, propelling their demand. Faster recuperation time resulting from smaller surgical cuts which create less tissue damage and speed up the healing process, make minimally invasive procedures advantageous. Consequently, patients can resume their daily routines sooner than they would following standard open surgeries, making it a popular choice for both the healthcare-givers and those receiving treatment. Arteriovenous malformations (AVMs) are conducive for minimally invasive procedures as they facilitate employing modern techniques such as endovascular embolization. It utilizes catheters and image-aligned interventions to decrease irregular blood flow whilst eliminating the necessity of an open surgery, hence mitigating risks, expediting recovery periods and enhancing patient results. As per the American Society of Plastic Surgeons, in September 2023, there were 25,442,640 cosmetic minimally invasive procedures conducted, marking an upsurge from 23,672,269 procedures in 2022. This translates to a 7% increment in minimally invasive treatments for both genders in 2023. Consequently, the growing preference for minimally invasive procedures is driving the expansion of the arteriovenous malformations market.

Which Segments Define The Structure Of The Arteriovenous Malformations Market?

The arteriovenous malformationsmarket covered in this report is segmented –

1) By Type: True Arteriovenous Malformation; Occult Or Cryptic; Cavernous Malformations; Venous Malformation; Hemangioma; Dural Fistula; Other Types

2) By Diagnosis: Physical examination; Brain Scans; Other Diagnosis

3) By Treatment: Endovascular Embolization; Neurosurgery

4) By Age Group: Adult Patients; Pediatric Patients

5) By End-User: Hospitals And Clinics; Research laboratories; Other End-Users

Subsegments:

1) By True Arteriovenous Malformation Type: Pial AVMs; Spinal AVMs; Brain AVMs; Extremity AVMs; Visceral AVMs

2) By Occult or Cryptic Type: Micro-AVMs; Hidden AVMs; Asymptomatic AVMs; Deep-Seated AVMs; Small-Scale AVMs

3) By Cavernous Malformations Type: Cerebral Cavernous Malformations (CCMs); Spinal Cavernous Malformations; Familial Cavernous Malformations; Solitary Cavernous Malformations; Multiple Cavernous Malformations

4) By Venous Malformation Type: Superficial Venous Malformations; Deep Venous Malformations; Mixed Venous Malformations; Syndromic Venous Malformations; Blue Rubber Bleb Nevus Syndrome

5) By Hemangioma Type: Infantile Hemangiomas; Capillary Hemangiomas; Lobular Capillary Hemangiomas; Cavernous Hemangiomas; Compound Hemangiomas

6) By Dural Fistula Type: Cranial Dural Arteriovenous Fistula (dAVF); Spinal Dural Arteriovenous Fistula; Direct Dural AV Fistula; Indirect Dural AV Fistula; High-Flow Dural Fistula

7) By Other Types: Lymphatic Malformations; Mixed Vascular Malformations; Arteriovenous Aneurysms; Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs; Rare Congenital AVMs

What Strategic Shifts And Innovations Are Influencing The Arteriovenous Malformations Market?

In the arteriovenous malformations market, companies are innovating with liquid embolic system procedural sets to streamline treatments and improve patient outcomes. These are pre-assembled, sterilized kits containing components needed to deliver liquid embolic agents for vascular malformations like AVMs. For example, in March 2024, CERENOVUS Inc., a US neurovascular company under Johnson & Johnson MedTech, launched the TRUFILL n-BCA liquid embolic system procedural set. This kit offers two configurations with all necessary accessories to prepare and deliver n-BCA embolic agents in a single sterilized package, optimizing cerebral AVM treatment preparation.

Which Firms Are Making The Biggest Impact In The Arteriovenous Malformations Market?

Major companies operating in the arteriovenous malformations market are Johnson And Johnson Services Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N V, Stryker Corporation, GE Healthcare Technologies Inc, Cedars-Sinai, Penn Medicine, Terumo Corporation, Eisai Co Ltd, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc., Penumbra Inc., Max Healthcare, RWJBarnabas Health, Balt LLC, Booking Health GmbH, Duke University Health System, Shape Memory Medical Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/arteriovenous-malformations-global-market-report

Which Region Is Forecasted To Lead The Arteriovenous Malformations Market In The Coming Years?

North America was the largest region in the arteriovenous malformations market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriovenous malformations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21888&type=smp

Browse Through More Reports Similar to the Global Arteriovenous Malformations Market 2025, By The Business Research Company

Animal Hospitals And Veterinary Clinics Market 2025

https://www.thebusinessresearchcompany.com/report/animal-hospitals-and-veterinary-clinics-market

Minimal Invasive Surgery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimal-invasive-surgery-devices-global-market-report

Small Electrical Appliance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-electrical-appliance-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model